As shown in Fig. 3A, CT26/HER2, CT26/HER2-A1, and CT26/HER2-A2 cells grew at the same rate when their tumor sizes were measured at 7 and 14 days following a tumor cell challenge. This evidence concerns the gene ERBB2 and neoplasm.